10x Genomics forecasts $625M-$635M 2026 revenue, targets ~50 Atera shipments
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: 10x Genomics (TXG) Q3 2026 MANAGEMENT VIEW * "Revenue for the third quarter was $151 million, up 1% year-over-year." (CEO Serge Saxonov) "The biggest highlight was the start of commercial shipments of Atera." (CEO Saxonov) * "Nearly all of the world's top…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralRevenue guidance and Atera shipment targets, against modest quarterly growth.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Third-quarter revenue was $151 million, up 1% year-over-year.
- 02Management targets about 50 Atera shipments by year-end.
- 03Sentira was announced as a new cloud analysis platform.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets